Villegas E, Arruñada M, Casado MA, González S, Moreno-Martínez E, Peñuelas MA, Torres AM, Sierra Y, Segui-Palmer MA
National expert consensus on home-administered oncologic therapies in Spain
Frontiers in Oncology. doi: 10.3389/fonc.2024.1335344
Narvaez JA, Bernabeu D, Muntaner L, Gomez F, Martel J, Castellano MM, García-Martos R, Britel R, Oyagüez I, Tejado N, Ortiz-Cruz E
Economic evaluation of percutaneous cryoablation vs conventional surgery in extra-abdominal desmoid tumours in the Spanish healthcare system
Insights into Imaging (2024) 15:1
Aguado JM, Navarro D, Montoto C, Yébenes M, de Castro-Orós I
Incidence of refractory CMV infection with or without antiviral resistance in Spain: A systematic literature review
Transplantation Reviews. doi: 10.1016/j.trre.2023.100804
MÁS INFORMACIÓN
Llaneras J, Ruiz-Cobo JC, Rando-Segura A, Barreira-Díaz A, Domínguez-Hernández R, Rodríguez-Frías F, Campins M, Colom J, Casado MA, Blanco-Grau A, Bañares J, Monforte A, Falcó A, Ruíz L, Meza B, Pumarola T, Riveiro-Barciela M, Esteban R, Buti M
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination
JHEP Reports 2024 vol. 6 j 100932
Casado MA, Moreno-Martínez ME, González S, Villegas E, Arruñada M, Peñuelas MA, Torres AM, Sierra Y, Seguí MA
Consenso de Expertos para la Administración Domiciliaria de Terapias Oncológicas: Recomendaciones clave para su implementación en España
11º Congreso Tendiendo Puentes. Toledo. 22-25 nov 2023
Martín A, Presa M, Tejado N, Pardo C, Martín-Escudero V, Oyagüez I, Ortiz-Maldonado V
Eficiencia de axicabtagén ciloleucel en el tratamiento en segunda línea del linfoma B difuso de células grandes en España
LXV Congreso Nacional de la SEHH, XXXIX Congreso Nacional de la SETH y III Congreso Iberoamericano de Hematología. Sevilla. 26-28 oct 2023
Pascual F, Ballesta Gómez R, Ruiz JJ, Colom i Farran J, Yébenes M, Casado MA
Complexity of HCV patients attended at addiction setting in Real-World Practice. results from Complexadic Study
The Liver Meeting, AASLD. Boston (EEUU). 10-14 nov 2023
Ortiz-Maldonado V, Presa M, Tejado N, Pardo C, Martín-Escudero V, Oyagüez I, Martín A
Axicabtagene Ciloleucel As Second-Line Treatment For Relapsed/ Refractory Large B-Cell Lymphoma In Spain: A Cost-Effectiveness Analysis Refractory Large B-Cell Lymphoma In Spain: A Cost-Effectiveness Analysis
26th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 12-15 nov 2023
Peral C, de Lossada Juste A, Lwoff N, Espinoza Cámac N, Martínez-Martínez N, Casado MÁ, Burke T, Kane A, Alvir J, Thakkar S, Ferri Grazzi E
Economic Burden of Moderate and Severe Hemophilia A and B in Spain, Real-World Evidence Insights from the Cost of Hemophilia in Europe: A Socio-Economic Survey II (CHESS II) Study
26th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 12-15 nov 2023
Parramon M, Juárez M, de Pedro S, Echave M, Oyagüez I, Casado MÁ, Martínez-Salamanca JI